Toxic epidermal necrolysis Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis

被引:124
作者
Schwartz, Robert A. [1 ]
McDonough, Patrick H. [1 ]
Lee, Brian W. [1 ]
机构
[1] Rutgers State Univ, Sch Med, Newark, NJ 07103 USA
关键词
apoptosis; drug eruption; erythema multiforme; granulysin; Stevens-Johnson syndrome; toxic epidermal necrolysis; STEVENS-JOHNSON-SYNDROME; CUTANEOUS ADVERSE-REACTIONS; NITRIC-OXIDE SYNTHASE; ERYTHEMA MULTIFORME; T-CELLS; HLA-B-ASTERISK-1502; ALLELE; HLA-B; HYPERSENSITIVITY REACTIONS; KERATINOCYTE DEATH; EFFECTOR-CELLS;
D O I
10.1016/j.jaad.2013.05.003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Toxic epidermal necrolysis is a life-threatening, typically drug-induced mucocutaneous disease. It is clinically characterized as a widespread sloughing of the skin and mucosa, including both external and internal surfaces. Histologically, the denuded areas show full thickness epidermal necrosis. The pathogenic mechanism involves antigenic moiety/metabolite, peptide-induced T cell activation, leading to keratinocyte apoptosis through soluble Fas ligand, perforin/granzyme B, tumor necrosis factor-alfa, and nitric oxide. Recent studies have implicated granulysin in toxic epidermal necrolysis apoptosis and have suggested that it may be the pivotal mediator of keratinocyte death.
引用
收藏
页码:173.e1 / 173.e13
页数:13
相关论文
共 117 条
[1]   Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand [J].
Abe, R ;
Shimizu, T ;
Shibaki, A ;
Nakamura, H ;
Watanabe, H ;
Shimizu, H .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1515-1520
[2]   Toxic epidermal necrolysis and Stevens-Johnson syndrome: Soluble Fas ligand involvement in the pathomechanisms of these diseases [J].
Abe, Riichiro .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 52 (03) :151-159
[3]   Granulysin as a Marker for Early Diagnosis of the Stevens-Johnson Syndrome [J].
Abe, Riichiro ;
Yoshioka, Naoya ;
Murata, Junko ;
Fujita, Yasuyuki ;
Shimizu, Hiroshi .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (07) :514-515
[4]   ERYTHEMA MULTIFORME EXUDATIVUM MAJOR (STEVENS-JOHNSON SYNDROME) [J].
ALEXANDER, MK ;
COPE, S .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1954, 68 (02) :373-+
[5]  
[Anonymous], 1995, NATURE
[6]   ERYTHEMA MULTIFORME WITH MUCOUS-MEMBRANE INVOLVEMENT AND STEVENS-JOHNSON SYNDROME ARE CLINICALLY DIFFERENT DISORDERS WITH DISTINCT CAUSES [J].
ASSIER, H ;
BASTUJIGARIN, S ;
REVUZ, J ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1995, 131 (05) :539-543
[7]   TOXIC EPIDERMAL NECROLYSIS - A REVIEW [J].
AVAKIAN, R ;
FLOWERS, FP ;
ARAUJO, OE ;
RAMOSCARO, FA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (01) :69-79
[8]  
Baldwin BT, 2010, J DRUGS DERMATOL, V9, P837
[9]   Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: Reports to the vaccine adverse event reporting system [J].
Ball, R ;
Ball, LK ;
Wise, RP ;
Braun, MM ;
Beeler, JA ;
Salive, ME .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (02) :219-223
[10]   CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME [J].
BASTUJIGARIN, S ;
RZANY, B ;
STERN, RS ;
SHEAR, NH ;
NALDI, L ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1993, 129 (01) :92-96